Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU2F2 is a pivotal transcription factor in lymphoid cells, especially B cells, where it is essential for immunoglobulin gene transcription and B-cell differentiation. It binds to the octamer sequence 5’-ATTTGCAT-3’ present in immunoglobulin gene promoters. Through activation of transcription, including anti-apoptotic genes, it sustains immune cell survival and maturation. POU2F2 plays a major role in various cancers, where its dysregulation leads to altered differentiation and cell survival. Furthermore, POU2F2 modulates cytokine gene expression and can affect immune checkpoints in malignancies. In viral infections like EBV, POU2F2 facilitates maintenance of latency through chromatin modification and enhancer binding. Outside immune tissues, its abnormal expression influences proliferation and metabolic reprogramming in diverse cancers and may regulate neuronal differentiation.
Drug interventions would most likely act by modulation of POU2F2's transcriptional activity, altering downstream gene expression related to survival, proliferation, and immune function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU class 2 homeobox 2 (POU2F2).